Abstract

Tumor associated neutrophils (TANs) and cytotoxic T cells (CTLs) are part of the tumor microenvironment of gastric cancer (GC). We explored their tumor biological significance in neoadjuvantly/perioperatively treated GC. Immunostaining was performed on whole tissue sections of 173 GCs, using antibodies directed against myeloperoxidase (MPO) and CD8. Stained specimens were digitalized, and the densities of TANs and CTLs were assessed separately in the mucosa, tumor surface, tumor center, invasion front, and tumor scar. The densities were correlated with clinicopathological patient characteristics. Compared with a historical cohort of 449 treatment naive GCs, the TAN density in the invasion front was significantly lower in neoadjuvantly/perioperatively treated GCs. TAN density in the tumor center and invasion front correlated with tumor regression. TAN density also correlated with CTL density in the tumor center and invasion front. A high density of CTL in the tumor center correlated with an improved overall survival and tumor specific survival. We show that neoadjuvant/perioperative (radio-) chemotherapy impacts on the immune microenvironment of GC, while also depending on sex. The density of TANs in neoadjuvantly/perioperatively treated GCs differed from findings made in a treatment naive GC cohort.

Highlights

  • Gastric cancer (GC) is the fifth most common cancer in the world

  • The overall incidence of cancer of the distal stomach is decreasing, while it is steadily increasing for adenocarcinomas of the cardia and gastroesophageal junction

  • Raw score values from the tumor-associated neutrophils (TANs) and CTL densities were dichotom to Lauren, 30 (17.3%) had a diffuse phenotype, 33 (19.1%) were mixed, and 18 (10.4%) were median and, regarding densities, unclassifiable

Read more

Summary

Introduction

Gastric cancer (GC) is the fifth most common cancer in the world. Its incidence shows substantial geographic variability, for example, being high in East Asia and low in Western countries [1]. The overall incidence of cancer of the distal stomach is decreasing, while it is steadily increasing for adenocarcinomas of the cardia and gastroesophageal junction. Known risk factors include an infection with Helicobacter pylori, smoking, higher age, high salt intake, obesity, chronic gastroesophageal reflux disease, and low physical activity [2,3]. The risk of suffering from GC is gender specific [4]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call